Illinois Tech Researchers Developing Novel COVID-19 Treatment that Targets Human Spike Protein to Stop Infection
CHICAGO—March 4, 2021 —Researchers at Illinois Institute of Technology (Illinois Tech) have filed a provisional patent for CROWNase—a new drug that has the potential to treat COVID-19 infections...